Barone Francesca, Nayar Saba, Campos Joana, Cloake Thomas, Withers David R, Toellner Kai-Michael, Zhang Yang, Fouser Lynette, Fisher Benjamin, Bowman Simon, Rangel-Moreno Javier, Garcia-Hernandez Maria de la Luz, Randall Troy D, Lucchesi Davide, Bombardieri Michele, Pitzalis Costantino, Luther Sanjiv A, Buckley Christopher D
Rheumatology Research Group, Centre for Translational Inflammation Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, B15 2WD, United Kingdom;
School of infection and Immunity, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom;
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11024-9. doi: 10.1073/pnas.1503315112. Epub 2015 Aug 18.
The series of events leading to tertiary lymphoid organ (TLO) formation in mucosal organs following tissue damage remain unclear. Using a virus-induced model of autoantibody formation in the salivary glands of adult mice, we demonstrate that IL-22 provides a mechanistic link between mucosal infection, B-cell recruitment, and humoral autoimmunity. IL-22 receptor engagement is necessary and sufficient to promote differential expression of chemokine (C-X-C motif) ligand 12 and chemokine (C-X-C motif) ligand 13 in epithelial and fibroblastic stromal cells that, in turn, is pivotal for B-cell recruitment and organization of the TLOs. Accordingly, genetic and therapeutic blockade of IL-22 impairs and reverses TLO formation and autoantibody production. Our work highlights a critical role for IL-22 in TLO-induced pathology and provides a rationale for the use of IL-22-blocking agents in B-cell-mediated autoimmune conditions.
组织损伤后黏膜器官中导致三级淋巴器官(TLO)形成的一系列事件仍不清楚。利用成年小鼠唾液腺中病毒诱导的自身抗体形成模型,我们证明白细胞介素-22(IL-22)在黏膜感染、B细胞募集和体液自身免疫之间提供了一种机制联系。IL-22受体的结合对于促进上皮和纤维母细胞基质细胞中趋化因子(C-X-C基序)配体12和趋化因子(C-X-C基序)配体13的差异表达是必要且充分的,而这种差异表达反过来对于B细胞募集和TLO的组织至关重要。因此,对IL-22的基因和治疗性阻断会损害并逆转TLO的形成和自身抗体的产生。我们的研究突出了IL-22在TLO诱导的病理过程中的关键作用,并为在B细胞介导的自身免疫性疾病中使用IL-22阻断剂提供了理论依据。